Ignite Creation Date:
2024-05-06 @ 7:17 PM
Last Modification Date:
2024-10-26 @ 3:04 PM
Study NCT ID:
NCT05963984
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-06-30
Brief Title:
A Study of Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants
Sponsor:
Carrick Therapeutics Limited
Organization:
Carrick Therapeutics Limited
Organization Data
Organization:
Carrick Therapeutics Limited
Class:
INDUSTRY
Study ID:
CT7001_002
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Carrick Therapeutics Limited
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Pfizer | INDUSTRY |